Type | Name | Gene Symbol | Clinical Significance | Chromosome | Start | Stop | Reference Allele | Alternate Allele | Review Status | Other IDs |
---|---|---|---|---|---|---|---|---|---|---|
(GRCh37) | ||||||||||
single nucleotide variant | NM_000059.4(BRCA2):c.631G>A (p.Val211Ile) | BRCA2 | Pathogenic | 13 | 32900750 | 32900750 | G | A | criteria provided, multiple submitters, no conflicts | ClinGen:CA023869 |
single nucleotide variant | NM_000059.4(BRCA2):c.632-1G>A | BRCA2 | Pathogenic | 13 | 32903579 | 32903579 | G | A | reviewed by expert panel | ClinGen:CA023882 |
single nucleotide variant | NM_000059.4(BRCA2):c.632-2A>G | BRCA2 | Pathogenic | 13 | 32903578 | 32903578 | A | G | reviewed by expert panel | ClinGen:CA023891 |
Deletion | NM_000059.4(BRCA2):c.6353_6366del (p.Val2118fs) | BRCA2 | Pathogenic | 13 | 32914843 | 32914856 | GTGTAAACTCAGAAA | G | reviewed by expert panel | ClinGen:CA023946 |
single nucleotide variant | NM_000059.4(BRCA2):c.6359C>G (p.Ser2120Ter) | BRCA2 | Pathogenic | 13 | 32914851 | 32914851 | C | G | reviewed by expert panel | ClinGen:CA023950 |
Deletion | NM_000059.4(BRCA2):c.6373del (p.Thr2125fs) | BRCA2 | Pathogenic | 13 | 32914860 | 32914860 | GA | G | reviewed by expert panel | Breast Cancer Information Core (BIC) (BRCA2):6601&base_change=del A,ClinGen:CA023958 |
single nucleotide variant | NM_000059.4(BRCA2):c.6382A>T (p.Lys2128Ter) | BRCA2 | Pathogenic | 13 | 32914874 | 32914874 | A | T | reviewed by expert panel | ClinGen:CA023965 |
Duplication | NM_000059.4(BRCA2):c.6390dup (p.Lys2131Ter) | BRCA2 | Pathogenic | 13 | 32914879 | 32914880 | A | AT | reviewed by expert panel | ClinGen:CA023972 |
Deletion | NM_000059.4(BRCA2):c.6393_6396del (p.Lys2131fs) | BRCA2 | Pathogenic | 13 | 32914884 | 32914887 | AAATT | A | reviewed by expert panel | ClinGen:CA023978 |
Deletion | NM_000059.4(BRCA2):c.63del (p.Ala22fs) | BRCA2 | Pathogenic | 13 | 32890658 | 32890658 | CA | C | reviewed by expert panel | Breast Cancer Information Core (BIC) (BRCA2):291&base_change=del A,ClinGen:CA023987 |